NASDAQ: MRNSMarinus Pharmaceuticals Inc Stock Forecast, Predictions & Price Target
Analyst price target for MRNS
Based on 8 analysts offering 12 month price targets for Marinus Pharmaceuticals Inc.
Min Forecast
$13.00+72.41%
Avg Forecast
$21.63+186.8%
Max Forecast
$32.00+324.4%
Should I buy or sell MRNS stock?
Based on 8 analysts offering ratings for Marinus Pharmaceuticals Inc.
Strong Buy
Strong Buy
3 analysts 37.5%
Buy
4 analysts 50%
Hold
1 analysts 12.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Be the first to know when Wall Street analysts revise their MRNS stock forecasts and price targets.
MRNS stock forecasts by analyst
| Analyst / Firm | Rating | Action | Price Target | Upside/Downside | Date | Analyst Color |
|---|---|---|---|---|---|---|
| Strong Buy | Reiterates | $28.00 | +271.35% | 2023-09-21 | ||
| Buy | Maintains | $21.00 | +178.51% | 2023-09-20 | ||
| Buy | Reiterates | $27.00 | +258.09% | 2023-09-20 | ||
| Strong Buy | Maintains | $32.00 | +324.40% | 2023-08-11 | ||
| Strong Buy | Maintains | $13.00 | +72.41% | 2023-08-11 | ||
| Buy | Maintains | $20.00 | +165.25% | 2023-08-11 | ||
| Hold | Downgrades | $14.00 | +85.68% | 2023-08-11 | ||
| Buy | Reiterates | $18.00 | +138.73% | 2023-05-30 |
Forecast return on equity
Is MRNS forecast to generate an efficient return?
Company
N/A
Industry
0.66%
Market
28.71%
Forecast return on assets
Is MRNS forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.05%
MRNS revenue growth forecast
How is MRNS forecast to perform vs Biotechnology companies and vs the US market?
Company
98.66%
Industry
34.31%
Market
8.24%
MRNS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MRNS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast
MRNS vs Biotech Stocks
Marinus Pharmaceuticals Stock Forecast FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.